Alexandra Martínez‐Roca

Author

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

Alexandra Martínez-Roca, Alexandra Martinez-Roca, Alexandra Martinez‐Roca, Alexandra Martínez-Roca, Alexandra Martínez‐Roca

Publications

294

Citations

H-Index

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona Universitat de Barcelona Josep Carreras Leukaemia Research Institute Centro de Investigación Biomédica en Red de Cáncer

About

Alexandra Martínez‐Roca is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	99
2	Immunology	2	2	57
3	Blood Transplantation	1	1	30
4	Cell Biology	1	1	28
5	Marrow Transplantation	1	1	30

Alexandra Martínez‐Roca

Publications

226

Citations

H-Index

Page 1

	Year	Citations
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe Gonzalo Gutiérrez, Montserrat Rovira, Nacira Arab, Bone Marrow Transplantation TransplantationMarrow TransplantationStem Cell TransplantationTransplantation MedicineHematology	2020	30
Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation Valentín Ortiz‐Maldonado, Gerard Frigola, Marta Español‐Rego, Frontiers in Oncology Hematological MalignancyTumor BiologyLymphoid NeoplasiaAlternative TherapyChronic Lymphocytic Leukemia	2022	29
Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy Miquel Blasco, Alexandra Martínez‐Roca, Luis Gerardo Rodríguez‐Lobato, British Journal of Haematology	2020	28
Venetoclax–based low intensity therapy in molecular failure of <i>NPM1</i>-mutated AML Carlos Jiménez‐Chillón, Jad Othman, David Taussig, Blood Advances Low Intensity TherapyMixed-phenotype Acute LeukemiaImmunologyPathologyBiological Therapy	2023	28
Results of <scp>ARI</scp>‐0001 <scp>CART19</scp> cell therapy in patients with relapsed/refractory <scp>CD19</scp>‐positive acute lymphoblastic leukemia with isolated extramedullary disease Valentín Ortiz‐Maldonado, Anna Alonso‐Saladrigues, Marta Español‐Rego, American Journal of Hematology	2022	23
Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines Pedro Puerta‐Alcalde, Mariana Chumbita, Paola Charry, Transplantation and Cellular Therapy	2021	22
The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever Luis Gerardo Rodríguez‐Lobato, Alexandra Martínez‐Roca, Sandra Castaño‐Díez, PLoS ONE	2020	17
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes Sandra Castaño‐Díez, Mònica López‐Guerra, Cristina Bosch-Castañeda, Cancers	2022	14
Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients Luis Gerardo Rodríguez‐Lobato, Alexandra Martínez‐Roca, David F. Moreno, Leukemia & lymphoma/Leukemia and lymphoma	2020	12
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome Francesca Guijarro, Mònica López‐Guerra, Jordi Morata, Blood Advances Hematological MalignancyMedicineGeneticsAcute Myeloid LeukemiaHematology	2023	12

Page 1